Silverback Asset Management’s Ibere Pharmaceuticals IBER Stock Holding History

Silverback Asset Management’s Portfolio IBER Stock Details IBER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-30,000	Closed	-$303K	–	117
2022 Q4	$303K	Hold	30,000	–	–	0.04%	102
2022 Q3	$297K	Buy	+30,000	New	+$296K	0.04%	99

Silverback Asset Management's IBER Position: Q1 2023 in Review

Silverback Asset Management sold out of Ibere Pharmaceuticals (IBER) in Q1 2023, closing a stake of 30,000 shares — an estimated $303K sold.

Silverback Asset Management first reported a position in IBER in Q3 2022 and held it in 2 quarters. The position peaked at $303K in Q4 2022. 0 funds tracked by Wall St. Rank hold IBER as of Q1 2023.

Silverback Asset Management reported no remaining Ibere Pharmaceuticals position as of Q1 2023 after selling out during the quarter.
Silverback Asset Management sold 30,000 Ibere Pharmaceuticals shares in Q1 2023, an estimated $303K.
Silverback Asset Management first reported a position in Ibere Pharmaceuticals in Q3 2022 and held it in 2 quarters.
Silverback Asset Management's Ibere Pharmaceuticals position peaked at $303K in Q4 2022.
0 funds tracked by Wall St. Rank held Ibere Pharmaceuticals as of Q1 2023.

Based on Silverback Asset Management's 13F filing for Q1 2023, filed 15 May 2023.